Novel Mechanism of Vasodilation in Inflammatory Bowel Disease
- 1 November 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 25 (11) , 2355-2361
Abstract
Objective— Endothelium-dependent dilation to acetylcholine (Ach) is reduced in mucosal arterioles from patients with inflammatory bowel disease (IBD). The contributions of both nitric oxide (NO) and endothelial-derived hyperpolarizing factor (EDHF) are decreased. We hypothesized that the remaining dilation results from products of cyclooxygenase. Methods and Results— High-performance liquid chromatography (HPLC) was used to isolate eicosanoid vasodilator products and videomicroscopy was used to examine vasomotor responses in human mucosal arterioles from subjects with or without IBD undergoing bowel resection surgeries. In subjects without IBD, Ach constricted (−52%±10%) arterioles devoid of endothelium. Indomethacin (INDO) (cyclooxygenase inhibitor) had no effect. In contrast, Ach dose-dependently dilated both intact and endothelial denuded arterioles from patients with IBD. The dilation was converted to constriction by INDO (−54%±9%; P 2 receptor antagonist). Only in arterioles from subjects with IBD did Ach produce an arachidonic acid metabolite that comigrated on HPLC with PG D 2 (PGD 2 ). Exogenous PGD 2 dilated (max=66%±4%) IBD arterioles. Conclusion— In arterioles from IBD patients, Ach-mediated dilation shifts from endothelial production of NO and EDHF to nonendothelial generation of a PG, likely PGD 2 . This is a novel dilator mechanism arising from nonendothelial vascular tissue that compensates for loss of endothelium-dependent dilation. PGD 2 appears to be important in regulating mucosal blood flow in patients with IBD, implicating potentially detrimental effects from nonsteroidal antiinflammatory drugs.Keywords
This publication has 23 references indexed in Scilit:
- 14,15-Epoxyeicosa-5( Z )-enoic AcidCirculation Research, 2002
- The coronary circulation in diabetes:Vascular Pharmacology, 2002
- Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.Journal of Clinical Investigation, 1996
- Characterization of a simple animal model for nonsteroidal anti-inflammatory drug induced antral ulcerCanadian Journal of Physiology and Pharmacology, 1993
- Evidence of Impaired Endothelium-Dependent Coronary Vasodilatation in Patients with Angina Pectoris and Normal Coronary AngiogramsNew England Journal of Medicine, 1993
- A new view of prostaglandin E regulation of the immune responseImmunology Today, 1991
- THE ROLE OF ENDOTHELIAL CELLS IN INFLAMMATIONTransplantation, 1990
- Bovine aortic endothelial cells display macrophage-like properties towards acetylated 125I-labelled low density lipoproteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis.Gut, 1980
- Determination of prostaglandin synthetase activity in rectal biopsy material and its significance in colonic disease.Gut, 1978